Search Within

Barbara Oldrini

Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. GSK Faculty (6)
  2. Human Oncology and Pathogenesis Program (6)
  3. Tow Center for Developmental Oncology (TCDO) (6)
  4. Sloan Kettering Institute Postdocs (4)
  5. Critical Care Center (3)
  6. Critical Care Center Leadership (3)

More Groups

People
  1. Ingo Mellinghoff (6)
  2. Carl Campos (5)
  3. Daniel Rohle (5)
  4. Barry Taylor (3)
  5. Cameron Brennan (3)
  6. Christian Grommes (3)

More People

Years
  1. 2017 (2)
  2. 2016 (1)
  3. 2013 (1)
  4. 2012 (1)
  5. 2010 (1)
Publications
  1. Molecular Biology of the Cell (2)
  2. Cancer Discovery (1)
  3. Nature Communications (1)
  4. Proceedings of the National Academy of Sciences of the United States of America (1)
  5. Science (1)
Publishers
  1. The American Society for Cell Biology (2)
  2. American Association for Cancer Research (1)
  3. American Association for the Advancement of Science (1)
  4. National Academy of Sciences (1)
  5. Nature Publishing Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of RAN binding protein 6 (RanBP6) as an EGFR feedback regulator and a tumor suppressor in glioblastoma
    Meeting Abstract

    Hsieh, W.; Oldrini, B.; Erdjument-Bromage, H.; Codega, P.; Carro, M. S.; Campos, C.; Taylor, B. S.; Tempst, P.; Squatrito, M.; Mellinghoff, I. K.
    Molecular Biology of the Cell (2017)

    Fulltext@MSK | Save
  • EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
    Journal Article

    Oldrini, B.; Hsieh, W. Y.; Erdjument-Bromage, H.; Codega, P.; Carro, M. S.; Curiel-García, A.; Campos, C.; Pourmaleki, M.; Grommes, C.; Vivanco, I.; more...
    Nature Communications (2017)

    Fulltext@MSK | Save
  • Identification of RAN binding protein 6 as EGFR feedback regulator and candidate tumor suppressor
    Meeting Abstract

    Hsieh, W.; Oldrini, B.; Erdjument-Bromage, H.; Codega, P.; Vivanco, I.; Rohle, D.; Campos, C.; Bielski, C. M.; Taylor, B. S.; Tempst, P.; more...
    Molecular Biology of the Cell (2016)

    Fulltext@MSK | Save
  • An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
    Journal Article

    Rohle, D.; Popovici-Muller, J.; Palaskas, N.; Turcan, S.; Grommes, C.; Campos, C.; Tsoi, J.; Clark, O.; Oldrini, B.; Komisopoulou, E.; more...
    Science (2013)

    Fulltext@MSK | Save
  • Differential sensitivity of glioma-versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors
    Journal Article

    Vivanco, I.; Robins, H. I.; Rohle, D.; Campos, C.; Grommes, C.; Nghiemphu, P. L.; Kubek, S.; Oldrini, B.; Chheda, M. G.; Yannuzzi, N.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation
    Journal Article

    Vivanco, I.; Rohle, D.; Versele, M.; Iwanami, A.; Kuga, D.; Oldrini, B.; Tanaka, K.; Dang, J.; Kubek, S.; Palaskas, N.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save